Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Net Margin (2022 - 2025)

Historic Net Margin for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 858.55%.

  • Lucid Diagnostics' Net Margin rose 1970000.0% to 858.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 1484.31%, marking a year-over-year decrease of 2354700.0%. This contributed to the annual value of 1220.09% for FY2024, which is 9490200.0% up from last year.
  • Latest data reveals that Lucid Diagnostics reported Net Margin of 858.55% as of Q3 2025, which was up 1970000.0% from 657.33% recorded in Q2 2025.
  • Lucid Diagnostics' Net Margin's 5-year high stood at 657.33% during Q2 2025, with a 5-year trough of 18880.26% in Q3 2022.
  • Its 4-year average for Net Margin is 4512.83%, with a median of 1811.78% in 2023.
  • In the last 5 years, Lucid Diagnostics' Net Margin surged by 170657000bps in 2023 and then tumbled by -25410100bps in 2025.
  • Lucid Diagnostics' Net Margin (Quarter) stood at 13328.57% in 2022, then soared by 92bps to 1041.35% in 2023, then grew by 7bps to 964.16% in 2024, then rose by 11bps to 858.55% in 2025.
  • Its last three reported values are 858.55% in Q3 2025, 657.33% for Q2 2025, and 4350.0% during Q1 2025.